Genmab A/S
CSE:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
CSE:GMAB
Watchlist
Price: 1 399 DKK 0.65% Market Closed
Market Cap: 92.6B DKK

Relative Value

The Relative Value of one GMAB stock under the Base Case scenario is 2 340.19 DKK. Compared to the current market price of 1 399 DKK, Genmab A/S is Undervalued by 40%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GMAB Relative Value
Base Case
2 340.19 DKK
Undervaluation 40%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
96
vs Industry
66
Median 3Y
9.6
Median 5Y
13.4
Industry
7
Forward
3.6
vs History
96
vs Industry
10
Median 3Y
31.9
Median 5Y
32.4
Industry
21.8
Forward
12.7
vs History
96
vs Industry
13
Median 3Y
25.7
Median 5Y
27.9
Industry
19.3
vs History
96
vs Industry
11
Median 3Y
27.7
Median 5Y
30.5
Industry
22.7
vs History
96
vs Industry
38
Median 3Y
5.3
Median 5Y
6.6
Industry
2.4
vs History
96
vs Industry
61
Median 3Y
8.1
Median 5Y
11.8
Industry
7.3
Forward
2.8
vs History
38
vs Industry
64
Median 3Y
4
Median 5Y
0
Industry
8.8
vs History
96
vs Industry
12
Median 3Y
21.7
Median 5Y
22.1
Industry
4
Forward
7.7
vs History
96
vs Industry
10
Median 3Y
21.7
Median 5Y
22.8
Industry
3.7
Forward
8.5
vs History
96
vs Industry
14
Median 3Y
22.1
Median 5Y
24.2
Industry
4.5
vs History
96
vs Industry
10
Median 3Y
23.4
Median 5Y
25.6
Industry
3.2
vs History
96
vs Industry
42
Median 3Y
17.8
Median 5Y
22.8
Industry
4.5

Multiples Across Competitors

GMAB Competitors Multiples
Genmab A/S Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
Genmab A/S
CSE:GMAB
88.9B DKK 4.1 11.3 9.2 9.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 35 020 097 -166 445.3 -202 117.7 -199 811.3
US
Abbvie Inc
NYSE:ABBV
342.1B USD 6.1 80.8 15.9 24.1
US
Amgen Inc
NASDAQ:AMGN
152.9B USD 4.6 37.4 15.4 27.2
US
Gilead Sciences Inc
NASDAQ:GILD
129.8B USD 4.5 270.4 10.6 13.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
128.7B USD 11.7 -240.4 26.3 27.6
US
Epizyme Inc
F:EPE
94.1B EUR 2 011.7 -513.3 -559 -544.1
AU
CSL Ltd
ASX:CSL
121.6B AUD 5.1 28.4 17.5 21.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
64B USD 4.5 14.5 9 10
US
Seagen Inc
F:SGT
39.3B EUR 19.4 -59.4 -64 -57.7
NL
argenx SE
XBRU:ARGX
34.6B EUR 17.9 47.1 -2 663.7 -1 785.9
P/S Multiple
Revenue Growth P/S to Growth
DK
Genmab A/S
CSE:GMAB
Average P/S: 3 183 835.1
4.1
16%
0.3
FR
Pharnext SCA
OTC:PNEXF
35 020 097
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.1
7%
0.9
US
Amgen Inc
NASDAQ:AMGN
4.6
4%
1.1
US
Gilead Sciences Inc
NASDAQ:GILD
4.5
3%
1.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
11.7
10%
1.2
US
E
Epizyme Inc
F:EPE
2 011.7
N/A N/A
AU
CSL Ltd
ASX:CSL
5.1
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.5
6%
0.8
US
S
Seagen Inc
F:SGT
19.4
30%
0.6
NL
argenx SE
XBRU:ARGX
17.9
39%
0.5
P/E Multiple
Earnings Growth PEG
DK
Genmab A/S
CSE:GMAB
Average P/E: 70
11.3
10%
1.1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -166 445.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
80.8
87%
0.9
US
Amgen Inc
NASDAQ:AMGN
37.4
44%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
270.4
187%
1.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -240.4 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -513.3 N/A N/A
AU
CSL Ltd
ASX:CSL
28.4
16%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.5
11%
1.3
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.4 N/A N/A
NL
argenx SE
XBRU:ARGX
47.1
28%
1.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DK
Genmab A/S
CSE:GMAB
Average EV/EBITDA: 14.8
9.2
20%
0.5
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -202 117.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.9
14%
1.1
US
Amgen Inc
NASDAQ:AMGN
15.4
17%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
10.6
7%
1.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.3
18%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -559 N/A N/A
AU
CSL Ltd
ASX:CSL
17.5
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
9
14%
0.6
US
S
Seagen Inc
F:SGT
Negative Multiple: -64 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -2 663.7 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
DK
Genmab A/S
CSE:GMAB
Average EV/EBIT: 19.1
9.7
19%
0.5
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -199 811.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
24.1
28%
0.9
US
Amgen Inc
NASDAQ:AMGN
27.2
31%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
13.4
11%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.6
15%
1.8
US
E
Epizyme Inc
F:EPE
Negative Multiple: -544.1 N/A N/A
AU
CSL Ltd
ASX:CSL
21.9
14%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
10
17%
0.6
US
S
Seagen Inc
F:SGT
Negative Multiple: -57.7 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -1 785.9 N/A N/A